NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Resistant Bacteria in Children in France

CompletedN/A

Sponsor: Association Clinique Thérapeutique Infantile du val de Marne

Conditions: Infection Due to Resistant Bacteria, Multi-antibiotic Resistance, Antibiotic Prescription, Risk Factors, Healing

Countries: France

This study is observational, multicenter and prospective study for surveillance of the use of new antibiotics in pediatrics for treated pediatrics infections due to multi-resistant bacteria

Eligibility overview

Sex: ALL

Age: — to 17 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Children under 18 years of age
* Hospitalized in France in a hospital center working with the ACTIV/GPIP network
* Treated with one or more of the following antibiotics:

  * Colimycin (Colistimethate sodium)
  * Cefiderocol
  * Aztreonam in combination
  * Ceftolozane-Tazobactam
  * Ceftazidime-avibactam
  * Meropenem/vaborbactam
  * Imipenem/Relebactam
  * Tigecycline
  * Daptomycin
  * Ceftaroline fosamil
  * Tedizolid phosphate
  * Fidaxomicin
  * Ceftobiprole
  * Dalbavancin

In association with a documented infection performed by:

* Blood culture
* Normally sterile site

  * Cerebrospinal fluid
  * Pleural fluid
  * Pleura
  * Peritoneum
  * Joint fluid
  * Other
* Urine sampling if the bacteria was considered responsible for the infection (associated with a leukocyturia ≥10,0000)
* Respiratory specimens if the bacteria was considered responsible for the infection
* Sampling on material such as:Intubation probe, Orthopedic, Urological, Central Nervous System (CNS),....

  * Related to colonization with multidrug-resistant bacteria without documentation.

Exclusion Criteria:

* Refusal of participation by the patient or his/her parent
* Medical history of mucoviscidosis

Locations (1)

Créteil, France